v3.25.2
Business Segments and Geographic Information
 9 Months Ended
Jun. 28, 2025
Segment Reporting [Abstract]  
Business Segments and Geographic Information Business Segments and Geographic Information
The Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges (such as intangible asset amortization expense, and goodwill and intangible asset impairment charges), transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.
Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and nine months ended June 28, 2025 and June 29, 2024. Segment information is as follows:

 Three Months EndedNine Months Ended
 June 28,
2025		June 29,
2024		June 28,
2025		June 29,
2024
Total revenues:
Diagnostics$448.9 $440.8 $1,373.1 $1,338.7 
Breast Health365.2 385.0 1,090.4 1,147.3 
GYN Surgical178.4 166.6 507.3 484.8 
Skeletal Health31.3 19.0 80.1 71.5 
$1,023.8 $1,011.4 $3,050.9 $3,042.3 
Income (loss) from operations:
Diagnostics$111.1 $89.7 $249.5 $210.1 
Breast Health99.6 102.4 262.8 296.2 
GYN Surgical48.8 56.7 (29.3)144.3 
Skeletal Health(4.9)(4.8)(5.6)2.0 
$254.6 $244.0 $477.4 $652.6 
Depreciation and amortization:
Diagnostics$46.7 $51.0 $143.8 $168.3 
Breast Health13.0 9.3 38.2 29.6 
GYN Surgical10.3 11.9 37.7 36.1 
Skeletal Health0.2 0.1 0.6 0.4 
$70.2 $72.3 $220.3 $234.4 
Capital expenditures:
Diagnostics$22.6 $17.7 $67.1 $61.7 
Breast Health3.5 10.4 15.3 25.1 
GYN Surgical7.5 4.8 20.3 11.5 
Skeletal Health— 0.7 — 1.1 
Corporate1.3 0.3 3.9 0.5 
$34.9 $33.9 $106.6 $99.9 
 
June 28,
2025		September 28,
2024
Identifiable assets:
Diagnostics$2,291.8 $2,431.3 
Breast Health1,572.8 1,588.9 
GYN Surgical1,652.1 1,419.9 
Skeletal Health35.5 48.3 
Corporate3,253.9 3,667.6 
$8,806.1 $9,156.0 

The Company had no customers that represented greater than 10% of consolidated revenues during the three and nine months ended June 28, 2025 and June 29, 2024.

The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “Rest of World” designation includes Canada, Latin America and the Middle East.
Revenues by geography as a percentage of total revenues were as follows:
 
 Three Months EndedNine Months Ended
 June 28,
2025		June 29,
2024		June 28,
2025		June 29,
2024
United States74.3 %75.7 %74.2 %74.9 %
Europe14.5 %12.6 %14.5 %13.4 %
Asia-Pacific5.9 %6.4 %5.9 %6.4 %
Rest of World5.3 %5.3 %5.4 %5.3 %
100.0 %100.0 %100.0 %100.0 %